Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stepped-care approach to treating MS: a managed care treatment algorithm.

Sheldon R Rich1, Imelda C Coleman, Richard Cook

  • 1SJR Associates LLC, West Bloomfield, Michigan 48323-3207, USA. SJRAssociates@aol.com

Journal of Managed Care Pharmacy : JMCP
|July 16, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Accuracy of Ultrasound for Adolescent Pelvic Avulsion Fractures: A Blinded Multirater Study.

Journal of clinical ultrasound : JCU·2026
Same author

In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

Vox sanguinis·2026
Same author

Effect of Nominal-Volume ("Double Tap") Postdilatation on Significant THV Mid-Stent Frame Underexpansion After Balloon-Expandable TAVR.

JACC. Cardiovascular interventions·2026
Same author

Britain's next research choice.

Science (New York, N.Y.)·2026
Same author

On-Table LM View to Predict Left Main Obstruction in TAV-in-TAV.

JACC. Cardiovascular interventions·2026
Same author

In vivo recovery and in vitro quality assessment of apheresis red blood cells stored for 42 days in non-DEHP disposable sets.

Vox sanguinis·2026

This study introduces a stepped-care treatment algorithm for multiple sclerosis (MS) to manage the chronic condition and delay disease progression. The model emphasizes platform therapy and adding agents as needed for effective long-term MS management.

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system inflammatory disorder.
  • MS is characterized by progressive disability and cognitive dysfunction.
  • Effective long-term management strategies are crucial for delaying MS progression.

Purpose of the Study:

  • To introduce a model treatment algorithm for MS management in managed care settings.
  • To provide a strategy for ongoing disease management and long-term care.
  • To delay disease progression, disability, and cognitive dysfunction in MS patients.

Main Methods:

  • Review of a stepped-care approach for MS treatment.
  • Concept of platform therapy providing baseline immunomodulatory action.

Related Experiment Videos

  • Consideration of factors for selecting platform therapy, including efficacy and neutralizing antibodies (NAbs).

    • Main Results:

    • Interferon beta (IFNbeta) products and glatiramer acetate are approved first-line therapies for relapsing MS.
    • IFNbetas are generally recommended as platform therapy due to demonstrated effects on relapses, MRI parameters, and disability progression.
    • Incidence of NAbs varies among IFNbeta formulations, potentially impacting efficacy.

    Conclusions:

    • A stepped-care approach is an effective method for managing MS.
    • The model algorithm aims to delay disease progression and associated disability and cognitive impairment.
    • Adding agents to platform therapy can improve disease control as MS progresses.